Ann-Marie Hulstine

Ann-Marie Hulstine has worked in the clinical operations field since 2003. Ann-Marie began their career at Merck Pharma as a Clinical Data Specialist in 2003. Ann-Marie then moved to SDI in 2005 as a Pharma Data Analyst. In the same year, they joined AstraZeneca Pharmaceuticals as a Sr. SDOS. From 2009 to 2014, they worked at Morphotek, Inc. in roles such as Project Manager of Clinical Operations and Clinical Operations Lead. In 2014, they became Manager of Clinical Operations at Tetralogic Pharmaceuticals. In 2016, they joined Immunocore Limited as a Senior Project Manager. From 2018 to 2020, they were Director of Clinical Operations at Aclaris Therapeutics, Inc. and, most recently, in 2021 they joined TriSalus Life Sciences as Sr. Director Clinical Operations.

Ann-Marie Hulstine obtained a Bachelor of Arts (B.A.) from Temple University in 2003. Ann-Marie also completed a certification in Building Resilience as a Leader from LinkedIn in April 2020.